Cannabis Users Lost Just as Much Weight After Bariatric Surgery as Non-Users

Despite cannabis being associated with increased appetite, bariatric surgery patients who used cannabis weekly had equivalent weight loss outcomes at every time point through two years.

Huang, Estella Y et al.·Surgical endoscopy·2023·Moderate EvidenceRetrospective Cohort·1 min read
RTHC-04634Retrospective CohortModerate Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Retrospective Cohort
Evidence
Moderate Evidence
Sample
N=364
Participants
N=364 adults undergoing sleeve gastrectomy, 8.5% cannabis users, US-based study.

What This Study Found

One of the most common concerns about cannabis use after bariatric surgery is the 'munchies' — cannabis stimulates appetite, and the whole point of bariatric surgery is to restrict eating. This study put that concern to the test and found it largely unfounded.

Among 364 sleeve gastrectomy patients, 31 (8.5%) were weekly cannabis users. The researchers tracked weight loss at 1 week, 1 month, 3 months, 6 months, 9 months, 1 year, and 2 years post-surgery. At every single time point, there was no significant difference in excess weight loss between cannabis users and non-users.

Interestingly, the cannabis group actually trended toward slightly more weight loss, though the difference wasn't statistically significant. Secondary outcomes — post-operative nausea and vomiting, length of hospital stay, readmission rates, and need for additional intervention — were also similar between groups.

This is reassuring data for the growing number of bariatric patients who use cannabis, whether medicinally or recreationally. The concern that appetite stimulation from cannabis would undermine surgical weight loss appears not to materialize in practice, at least through two years of follow-up.

Key Numbers

364 sleeve gastrectomy patients: 31 cannabis users (8.5%), 333 non-users. No significant difference in excess weight loss at any time point from 1 week through 2 years. Post-operative nausea/vomiting, length of stay, readmission, and reintervention rates were comparable between groups.

How They Did This

Retrospective cohort study of 364 sleeve gastrectomy patients divided into cannabis users (at least once weekly, n=31) and non-users (n=333). Primary outcome was excess weight loss (EWL) at multiple time points through 2 years. Secondary outcomes included post-operative nausea/vomiting, length of stay, readmission, and need for additional intervention. Cannabis users were also surveyed by phone for additional information.

Why This Research Matters

About 8% of bariatric surgery patients use cannabis, and that number is growing as legalization expands. Surgeons and patients need to know whether cannabis use will compromise outcomes. This study provides the first focused evidence that it doesn't — giving clinicians data to counsel patients rather than relying on theoretical concerns about appetite stimulation.

The Bigger Picture

This study challenges a simplistic understanding of cannabis and appetite. While THC does stimulate appetite acutely, the long-term metabolic picture is more complex. Epidemiological studies have consistently shown that cannabis users tend to have lower BMI than non-users — a paradox this surgical data reinforces. The findings connect to broader questions about cannabis and metabolism that cut across the research database.

What This Study Doesn't Tell Us

Retrospective design with a small cannabis user group (31 patients). Cannabis use was self-reported and defined broadly as 'at least once weekly' — dosage, potency, and route of administration varied. No data on whether cannabis use patterns changed after surgery. Single-center study (sleeve gastrectomy only, not gastric bypass). The cannabis group may differ from non-users in unmeasured ways. Two-year follow-up, while meaningful, may not capture very long-term differences.

Questions This Raises

  • ?Does the route of cannabis consumption (edibles vs. smoked) affect post-surgical eating patterns differently?
  • ?Would higher-frequency or higher-dose cannabis use produce different results?
  • ?Does cannabis use affect micronutrient absorption or nutritional outcomes after bariatric surgery, even if weight loss is comparable?

Trust & Context

Key Stat:
Evidence Grade:
This is a retrospective cohort study with a reasonable sample but a small cannabis user subgroup (31 patients). The consistent null finding across multiple time points is reassuring but should be confirmed in larger, prospective studies.
Study Age:
Published in 2023. As cannabis legalization expands, more bariatric programs may begin collecting cannabis use data prospectively.
Original Title:
Weight loss outcomes are not compromised in bariatric patients using cannabis.
Published In:
Surgical endoscopy, 37(3), 2194-2201 (2023)Surgical Endoscopy is a peer-reviewed journal focused on minimally invasive surgery.
Database ID:
RTHC-04634

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Looks back at existing records to find patterns.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-04634·https://rethinkthc.com/research/RTHC-04634

APA

Huang, Estella Y; Broderick, Ryan C; Li, Jonathan Z; Serra, Joaquin L; Ahuja, Pranav; Wu, Samantha; Genz, Michael; Grunvald, Eduardo; Kunkel, David C; Sandler, Bryan J; Horgan, Santiago; Jacobsen, Garth R. (2023). Weight loss outcomes are not compromised in bariatric patients using cannabis.. Surgical endoscopy, 37(3), 2194-2201. https://doi.org/10.1007/s00464-022-09453-x

MLA

Huang, Estella Y, et al. "Weight loss outcomes are not compromised in bariatric patients using cannabis.." Surgical endoscopy, 2023. https://doi.org/10.1007/s00464-022-09453-x

RethinkTHC

RethinkTHC Research Database. "Weight loss outcomes are not compromised in bariatric patien..." RTHC-04634. Retrieved from https://rethinkthc.com/research/huang-2023-weight-loss-outcomes-are

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.